Trial intelligence / Profile preview

Telmisartan vs Losartan in Mild-to-Moderate Hypertension

NCT02200640Phase 4Completed

Sponsor
Boehringer Ingelheim
Start
Mar 2000
Primary completion
Dec 2000
Modality
Small Molecules
01

Overview

A Phase 4 trial of telmisartan in hypertension (HTN), sponsored by Boehringer Ingelheim. Started Mar 2000; status: completed.

02

Drugs

telmisartan
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT02200640.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02200640.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call